{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-088079","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.392732+00:00","generated_at":"2026-06-12T03:48:16.971294+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Collegium enters $50M accelerated share repurchase under $100M buyback program","bullets":["$50 million ASR agreement with Jefferies LLC; initial delivery of ~1.7M shares (80% of expected) based on $23.49 close","Final settlement expected in Q4 2023 based on volume-weighted average price during term","Part of $100M share repurchase program authorized by Board in January 2023","As of June 30, 2023, approximately 34.7 million shares outstanding"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-088079","json":"https://secwatch.observer/filing/0001104659-23-088079.json","markdown":"https://secwatch.observer/filing/0001104659-23-088079.md","text":"https://secwatch.observer/filing/0001104659-23-088079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923088079/0001104659-23-088079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923088079/tm2323003d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T03:48:16.971294+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}